System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Pau Llàcer is an expert in Cardiology at Hospital Universitario Ramón y Cajal (Spain). As of October 2026, ScienceLeadR ranks Pau Llàcer in the top 1% of experts worldwide for Heart Failure. Pau Llàcer has authored 140 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 6 of them ongoing. SLR score: 703 (community average: 125). How the SLR is computed.

LeadR Profile

Pau Llàcer Hospital Universitario Ramón y Cajal Spain
703 ScienceLeadR Reputation 703

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Internal Medicine - Public Health - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2014 - 2026
Source: PubMed

Hospital Universitario Ramón y Cajal

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 140

Citations

Citations: 2 177 1st author: 23 Last author: 0 Unique author: 0

Main journals

ESC Heart Fail 11
Eur J Intern Med 11
Rev Esp Cardiol (Engl Ed) 11
Rev Clin Esp (Barc) 10
Eur J Heart Fail 9

Best Journals

Eur Heart J 2
Ann Intern Med 1
JAMA 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study.
PMID 42734113 — prealbumin, comparative effectiveness research, therapeutics, amyloid, cardiomyopathies, transthyretin amyloid cardiomyopathy		J Comp Eff Res20260
Lower-limb compression in AHF and predominant tissue congestion: rationale and design of the COMPRESSION-HF trial.
PMID 42583743 — heart failure, vena cava, inferior, natriuresis, diuretics, therapeutics, furosemide, tissues		ESC Heart Fail20260
Prognostic performance of the BAN-ADHF score in acute decompensated heart failure: a sub-analysis of the Spanish Heart Failure Registry (RICA).
PMID 42565965 — registries, mortality, hospitalization, heart failure, internal medicine, heart		Intern Emerg Med20260
Chronic obstructive pulmonary disease and CA125 levels in ambulatory chronic heart failure: The COPA-HF study.
PMID 42425178 — pleural effusion, heart failure, heart, cardiology, pulmonary disease, chronic obstructive, lung diseases, outpatients, lung diseases, obstructive		Int J Cardiol20260
Worsening renal function in acute heart failure: a hemoconcentration-conditioned interpretation with ranges of benefit, safety, and harm.
PMID 42413651 — creatinine, safety, hospitalization, heart failure, heart, cardiovascular diseases, therapeutics		Rev Esp Cardiol (Engl Ed)20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 8
Phase 4 4
N/A 3
Phase 2 3

By status:

Completed 9
Recruiting 4
Active not recruiting 2
Terminated 2
Unknown 1

By type:

Interventional 17
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 2
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 8

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
HF POLARIS A research study to look at how well NNC0487 0111 works compared to placebo in people with heart failure and obesity
2025-523717-29-00 — mortality, safety, heart failure, heart, heart failure, diastolic, obesity, morbidity, research		Phase 3Recruiting2026
202301CPC Redefine HF
2023-508581-15-00 — mortality, safety, heart failure, heart, morbidity		Phase 3Recruiting2024
ATHENA A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation
2023-506988-34-00 — heart failure, heart, signs and symptoms, research		Phase 3Active not recruiting2024
Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure
NCT07597512 — point-of-care systems, heart failure, heart, biomarkers, diuretics		N/ARecruiting2026
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION HF)
2023-508874-27-00 — sodium-glucose transporter 2 inhibitors, safety, heart failure, heart		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS